Get started
Author

Orla McGarvey

Observed name: McGarvey, Orla
Institution: Lonza (Switzerland)
Observed institution: Lonza (Switzerland)
ORCID: 0009-0001-0746-5973
Observed ORCID: 0009-0001-0746-5973
OpenAlex ID: A5002167209
Best Practices and Guidelines (2022) for Scale-Up and Tech Transfer in Freeze-Drying Based on Case Studies. Part 1: Challenges during Scale Up and Transfer
2022 · Serguei Tchessalov, Evgenyi Shalaev, et al. · AAPS PharmSciTech · 42
PDF
Best Practices and Guidelines (2022) for Scale-up and Technology Transfer in Freeze Drying Based on Case Studies. Part 2: Past Practices, Current Best Practices, and Recommendations
2023 · Serguei Tchessalov, Evgenyi Shalaev, et al. · AAPS PharmSciTech · 22
PDF
Lyophilizer Leak Rate Testing – An Industry Survey and Best Practice Recommendation
2022 · Ekneet Sahni, Bert Van Meervenne, et al. · Journal of Pharmaceutical Sciences · 8
PDF
Antibody–Drug Conjugates Drug Product Formulation and Process Development, Scalability and Stability Considerations
2026 · Léa Sorret, Mamiko Ninomiya, et al. · AAPS PharmSciTech · 2
Pharmaceutical compositions comprising anti-191P4D12 antibody drug conjugates and methods of use thereof
2025 · McGarvey, Orla, Ratnaswamy, Gayathri, et al. · Zenodo (CERN European Organization for Nuclear Research)
Works count: 5
Citation count: 74
H-index: 3
I10-index: 2
Year
Topic
Type